Who Paid My Doc
Product in Development
Device Devices
General payments
$7,483,403
Research payments
$24,667,228
Through program year 2025, $7,483,403 in general payments and $24,667,228 in research payments were reported against Product in Development (Devices).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
14 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,429,816 | 1,255 |
| 2025 | Research | $2,240,040 | 502 |
| 2024 | General | $866,088 | 976 |
| 2024 | Research | $3,685,508 | 717 |
| 2023 | General | $907,048 | 636 |
| 2023 | Research | $3,383,472 | 865 |
| 2022 | General | $811,820 | 433 |
| 2022 | Research | $3,170,065 | 925 |
| 2021 | General | $652,943 | 456 |
| 2021 | Research | $3,540,096 | 1,080 |
| 2020 | General | $946,768 | 584 |
| 2020 | Research | $4,044,502 | 1,003 |
| 2019 | General | $1,868,920 | 1,079 |
| 2019 | Research | $4,603,546 | 1,003 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 27 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 33 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
5,419 general · 6,095 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.